Advertisement

Optimal Surgical Treatment for Type 2 Diabetes

Sleeve Gastrectomy or Gastric Bypass?
      Randomized trials have shown that sleeve gastrectomy and gastric bypass induce similar improvements in type 2 diabetes after 5 years of follow-up.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rubino F.
        • Kaplan L.M.
        • Schauer P.R.
        • et al.
        The diabetes surgery summit consensus conference: Recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus.
        Ann Surg. 2010; 251: 399-405
        • Pories W.J.
        • Swanson M.S.
        • MacDonald K.G.
        • et al.
        Who would have thought it? An operation proves to Be the most effective therapy for adult-onset diabetes mellitus. vol. 222. Lippincott-Raven Publishers, 1995
        • Pories W.J.
        • Swanson M.S.
        • MacDonald K.G.
        • et al.
        Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus..
        Ann Surg. 1995; 222 (discussion 350-2): 339-350
        • Kohli R.
        • Stefater M.A.
        • Inge T.H.
        Molecular insights from bariatric surgery.
        Rev Endocr Metab Disord. 2011; 12: 211-217
        • Kamvissi-Lorenz V.
        • Raffaelli M.
        • Bornstein S.
        • et al.
        Role of the Gut on Glucose Homeostasis: Lesson Learned from Metabolic Surgery.
        Curr Atheroscler Rep. 2017; 19https://doi.org/10.1007/s11883-017-0642-5
        • English W.J.
        • DeMaria E.J.
        • Hutter M.M.
        • et al.
        American Society for Metabolic and Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States.
        Surg Obes Relat Dis. 2020; 16: 457-463
        • Kumar S.B.
        • Hamilton B.C.
        • Wood S.G.
        • et al.
        Is laparoscopic sleeve gastrectomy safer than laparoscopic gastric bypass? a comparison of 30-day complications using the MBSAQIP data registry.
        Surg Obes Relat Dis. 2018; 14: 264-269
        • Scott W.R.
        • Batterham R.L.
        Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery.
        Am J Physiol Regul Integr Comp Physiol. 2011; 301: 15-27
        • Wallenius V.
        • Alaraj A.
        • Björnfot N.
        • et al.
        Sleeve gastrectomy and Roux-en-Y gastric bypass in the treatment of type 2 diabetes. Two-year results from a Swedish multicenter randomized controlled trial.
        Surg Obes Relat Dis. 2020; 16: 1035-1044
        • Salminen P.
        • Helmio M.
        • Ovaska J.
        • et al.
        Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-y gastric bypass onweight loss at 5 years among patients with morbid obesity the SLEEVEPASS randomized clinical trial.
        JAMA. 2018; 319: 241-254
        • Peterli R.
        • Wolnerhanssen B.K.
        • Peters T.
        • et al.
        Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-y gastric bypass onweight loss in patients with morbid obesity the sm-boss randomized clinical trial.
        JAMA. 2018; 319: 255-265
        • Murphy R.
        • Clarke M.G.
        • Evennett N.J.
        • et al.
        Laparoscopic Sleeve Gastrectomy Versus Banded Roux-en-Y Gastric Bypass for Diabetes and Obesity: a Prospective Randomised Double-Blind Trial.
        Obes Surg. 2018; 28: 293-302
        • Schauer P.R.
        • Bhatt D.L.
        • Kirwan J.P.
        • et al.
        Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes.
        N Engl J Med. 2017; 376: 641-651
        • Yang J.
        • Wang C.
        • Cao G.
        • et al.
        Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m2.
        BMC Surg. 2015; 15https://doi.org/10.1186/s12893-015-0074-5
        • Kahn S.E.
        • Hull R.L.
        • Utzschneider K.M.
        Mechanisms linking obesity to insulin resistance and type 2 diabetes.
        Nature. 2006; 444https://doi.org/10.1038/nature05482
        • Nishimura S.
        • Manabe I.
        • Nagasaki M.
        • et al.
        CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.
        Nat Med. 2009; 15: 914-920
        • Ohashi K.
        • Yuasa D.
        • Shibata R.
        • et al.
        Adiponectin as a Target in Obesity-related Inflammatory State.
        Endocr Metab Immune Disorders-Drug Targets. 2015; 15: 145-150
        • Woods S.C.
        • D’Alessio D.A.
        Central Control of Body Weight and Appetite.
        J Clin Endocrinol Metab. 2008; 93: s37-s50
        • Seeley R.
        • van Dijk G.
        • Campfield L.
        • et al.
        Intraventricular Leptin Reduces Food Intake and Body Weight of Lean Rats but Not Obese Zucker Rats.
        Horm Metab Res. 1996; 28: 664-668
        • Liu J.
        • Yang X.
        • Yu S.
        • et al.
        The Leptin Resistance.
        Adv Exp Med Biol. 2018; 1090: 145-163
        • Field B.C.T.
        • Chaudhri O.B.
        • Bloom S.R.
        Bowels control brain: gut hormones and obesity.
        Nat Rev Endocrinol. 2010; 6: 444-453
        • Turnbaugh P.J.
        • Ley R.E.
        • Mahowald M.A.
        • et al.
        An obesity-associated gut microbiome with increased capacity for energy harvest.
        Nature. 2006; 444: 1027-1031
        • Müller T.D.
        • Nogueiras R.
        • Andermann M.L.
        • et al.
        Ghrelin.
        Mol Metab. 2015; 4: 437-460
        • Cummings D.E.
        • Weigle D.S.
        • Frayo R.S.
        • et al.
        Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery.
        N Engl J Med. 2002; 346: 1623-1630
        • Karamanakos S.N.
        • Vagenas K.
        • Kalfarentzos F.
        • et al.
        Weight Loss, Appetite Suppression, and Changes in Fasting and Postprandial Ghrelin and Peptide-YY Levels After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy.
        Ann Surg. 2008; 247: 401-407
        • Batterham R.L.
        • Cohen M.A.
        • Ellis S.M.
        • et al.
        Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36.
        N Engl J Med. 2003; 349: 941-948
        • Korner J.
        • Bessler M.
        • Cirilo L.J.
        • et al.
        Effects of Roux-en-Y Gastric Bypass Surgery on Fasting and Postprandial Concentrations of Plasma Ghrelin, Peptide YY, and Insulin.
        J Clin Endocrinol Metab. 2005; 90: 359-365
        • McCarty T.R.
        • Jirapinyo P.
        • Thompson C.C.
        Effect of Sleeve Gastrectomy on Ghrelin, GLP-1, PYY, and GIP Gut Hormones.
        Ann Surg. 2020; 272: 72-80
        • Bose M.
        • Oliván B.
        • Teixeira J.
        • et al.
        Do Incretins Play a Role in the Remission of Type 2 Diabetes after Gastric Bypass Surgery: What are the Evidence?.
        Obes Surg. 2009; 19: 217-229
        • Wallenius V.
        • Dirinck E.
        • Fändriks L.
        • et al.
        Glycemic Control after Sleeve Gastrectomy and Roux-En-Y Gastric Bypass in Obese Subjects with Type 2 Diabetes Mellitus.
        Obes Surg. 2018; 28: 1461-1472
        • MacDonald P.E.
        • El-kholy W.
        • Riedel M.J.
        • et al.
        The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion.
        Diabetes. 2002; 51: S434-S442
        • Baggio L.L.
        • Drucker D.J.
        Biology of Incretins: GLP-1 and GIP.
        Gastroenterology. 2007; 132: 2131-2157
        • Ahmad T.R.
        • Haeusler R.A.
        Bile acids in glucose metabolism and insulin signalling — mechanisms and research needs.
        Nat Rev Endocrinol. 2019; 15: 701-712
        • Albaugh V.L.
        • Banan B.
        • Ajouz H.
        • et al.
        Bile acids and bariatric surgery.
        Mol Aspects Med. 2017; 56: 75-89
        • Palleja A.
        • Kashani A.
        • Allin K.H.
        • et al.
        Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota.
        Genome Med. 2016; 8: 67
        • Liu H.
        • Hu C.
        • Zhang X.
        • et al.
        Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes.
        J Diabetes Invest. 2018; 9: 13-20
        • Cummings D.E.
        Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery.
        Int J Obes. 2009; 33: S33-S40